MGTX (MeiraGTx Corp) Margin dodolan resik

Lambang korporat lan logo MeiraGTx (MGTX)

MeiraGTx Holdings plc (MGTX) is recognized as a leader in genetic modification, having earned authority among biomedical professionals. Its proprietary vector manufacturing plants strengthen the firm's position by minimizing risks during drug development. Revenues are based on therapies for neurodegenerative pathologies and retinal diseases. Financial sales margins demonstrate capital efficiency, while the 19.50 indicator reflects the status of current return on assets.

MeiraGTx Holdings plc (MGTX) - Margin dodolan perusahaan saka 04.07.2022 nganti 20.11.2026

Rincian metrik lan analitis perusahaan MeiraGTx Corp (MGTX)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:MeiraGTx, MGTX
Barang unggulan MeiraGTx PLC

MeiraGTx Holdings plc (MGTX) capacity to withstand operational downturns is limited by a lack of stable sales and a dependence on volatile payments from gene therapy partners. The current value of 19.50 for annual net margin reflects the portion of revenue remaining after all expenses, allowing investors to assess the real efficiency of the business; however, for a final conclusion, this data must be compared with the cost of capital.

Karo sapa MeiraGTx Holdings plc saingan

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX